ANAVEX 2-73 named 2010’s ‘most promising trial drug’ by Alzheimer’s Weekly Anavex Existence Sciences Corp Click to read more . announced today that ANAVEX 2-73 has been named 2010’s ‘most promising trial medication’ by the editorial staff at Alzheimer’s Weekly. Related StoriesMore analysis needed before recommending antidepressants, Alzheimer's disease medications for stroke recovery: StudyCollaborative approach may quickness discovery of new preventive remedies for Alzheimer's diseaseResearchers identify role of microglia during early stages of Alzheimer's disease’It is extremely rewarding for our team to get such significant and independent third-party recognition for ANAVEX 2-73 and our unique strategy in Alzheimer’s disease,’ stated Dr.
Only 8 percent believed long term care should be supplied in the U.S. Eighty-three % of most likely voters were very or somewhat concerned that america will add 135 million people to its population in the next 40 years, 75 percent of which is due to immigration. Republicans had been more concerned than Democrats . Seventy-eight % of likely voters were against legalizing the status of the estimated 12 million illegal immigrants in the U.S. With only 19 percent supporting it. 88 percent of African-Americans were opposed to legalization. Fifty-five % were opposed to a government insurance option under any national health care plan with 28 percent in favor and 17 percent uncertain.